Download PDF

Other users also viewed these articles

Clinical and economic benefit of 32 years of antiretroviral treatment for people living with HIV in Spain: Has it been an efficient intervention? Maria Jesús Pérez-Elías; Daniel Podzamczer Palter; Pere Ventayol Bosch; Inmaculada Jarrín; Antonio Castro; Darío Rubio-Rodríguez; Carlos Rubio-Terrés;
Enferm Infecc Microbiol Clin. 2022;40:550-6
Screening for sexually transmitted infections in the transgender population and interaction of gender-affirming hormonal treatment with antiretroviral therapy Esteban Sánchez-Toscano; Dunia Collazo-Yáñez; Jesús Domínguez-Riscart; Laura Larrán-Escandón; Andrés Martín-Aspas; Isabel Mateo-Gavira; Manuel Aguilar-Diosdado;
Enferm Infecc Microbiol Clin. 2025;43:585-90
Cost analysis associated with intramuscular versus oral administration of antiretroviral therapy in the management of human immunodeficiency virus infection Vicente Estrada; Juan Emilio Losa; Ramón Morillo-Verdugo; Montserrat Pérez-Encinas; Jesús Santos; Antonio Castro; María Presa González; Laura Salinas-Ortega;
Enferm Infecc Microbiol Clin. 2025;43:251-9